You just read:

Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma

News provided by

Onyx Pharmaceuticals, Inc.

Apr 26, 2012, 08:55 ET